基于血液的设计是否会成为第四代心脏辅助器件的信号?
Michael J Simmonds1, Bente Thamsen2, Salim E Olia3
1Biorheology Research Laboratory, Griffith University, Gold Coast, Australia.
概括
机械循环支持装置的临床前评估协议需要改进. 解决血液检测,模拟和动物模型的局限性对于开发更安全,更有效的第四代心脏辅助设备至关重要.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 医疗器械开发 医疗器械开发
背景情况:
- 机械循环支持 (MCS) 设备为严重心胸疾病提供了心脏移植的替代方案.
- 进步已经提高了耐用性和生存率,但最近的进展由于出血和器官衰竭等并发症而停滞不前.
- 已批准的心室辅助器件 (VAD) 的故障凸显了重新评估临床前评估的必要性.
研究的目的:
- 批判性地检查当前临床前评估协议在MCS设备的设计和开发中的作用和有效性.
- 确定现有的临床前检测方法的局限性,这些局限性可能导致不良的临床结果.
- 为加强临床前评估提出解决方案,以提高未来MCS设备的可靠性和安全性.
主要方法:
- 对MCS技术的发展途径的分析.
- 检查基板血液检测,计算设计和模拟以及动物试验的局限性.
- 探索跨学科和开放的医疗器械开发方法.
主要成果:
- 目前的临床前评估方案可能无法提供未来临床性能的现实概况.
- 血液相容性测试,模拟准确性和动物模型相关性的局限性导致不良事件.
- 现有的方法可能无法充分预测设备相关的并发症,如内部出血和多系统器官衰竭.
结论:
- 对于MCS器件的临床前评估协议需要显著改进,以确保临床安全性和有效性.
- 通过跨学科合作克服局限性对于开发下一代心脏辅助设备至关重要.
- 通过改善临床前评估来解决与血红相容性相关的不良事件 (HRAE) 是推动MCS技术发展的关键.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
3.6K
相关概念视频
01:30Equipments Used To Measure Blood Pressure
Direct Method
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...